Why is vaccination evaluation important for immunocompromised patients, and what vaccines should be considered?

• A. Live vaccines are contraindicated in severe immunosuppression; consider inactivated vaccines and keep up-to-date; consult guidelines.
• B. Vaccination is unnecessary in immunocompromised patients.
• C. Only the influenza vaccine is important in immunocompromised patients.
• D. Live vaccines are always safe and should be given on a strict schedule.

Answer: (A)

Vaccination evaluation for immunocompromised patients hinges on safety and effectiveness, given that their immune systems may respond differently and live vaccines can pose real risks. In severe immunosuppression, live vaccines are typically contraindicated because they can cause vaccine‑associated disease or disseminate in the setting of a weakened immune response. The safest path is to prioritize inactivated vaccines, which are generally well tolerated, while recognizing that immune responses may be blunted and may require additional doses or timing adjustments.

A clinician should assess the patient’s vaccine history, current level of immunosuppression, and any therapies that could affect vaccine safety or efficacy. When possible, vaccination should be optimized before starting immunosuppressive treatment or during a window of lower immunosuppression, and guidelines from bodies such as ACIP/CDC should guide the schedule and catch‑up plan. Key vaccines to consider include the inactivated influenza vaccine each season, pneumococcal vaccines (PCV13 followed by PPSV23 with timing tailored to immune status), hepatitis A and B vaccines as indicated by risk, and age-appropriate diphtheria/tetanus/pertussis, polio, and meningococcal vaccines. The recombinant zoster vaccine is preferred over the live zoster vaccine for many immunocompromised patients. Live vaccines such as MMR, varicella, and the traditional live attenuated influenza vaccine are generally avoided in those with significant immune suppression. Vaccination of close contacts and healthcare workers is also important to reduce exposure risk. The overarching message is to carefully evaluate safety, timing, and appropriate vaccine types to provide protection without compromising safety, following current professional guidelines.